The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.
USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.
In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.
The global Insulin Glargine market was valued at US$ 6461 million in 2020 and is expected to reach US$ 8487.8 million by the end of 2027, growing at a CAGR of 4.0% during 2021-2027.
This report focuses on Insulin Glargine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Insulin Glargine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Insulin Glargine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Treat Type2 Diabetes
Treat Type1 Diabetes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi-Aventis
Ganlee
Biocon
nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.
USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.
In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.
The global Insulin Glargine market was valued at US$ 6461 million in 2020 and is expected to reach US$ 8487.8 million by the end of 2027, growing at a CAGR of 4.0% during 2021-2027.
This report focuses on Insulin Glargine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Insulin Glargine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Insulin Glargine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Treat Type2 Diabetes
Treat Type1 Diabetes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi-Aventis
Ganlee
Biocon
Index1 Insulin Glargine Market Overview
1.1 Product Overview and Scope of Insulin Glargine
1.2 Insulin Glargine Segment by Type
1.2.1 Global Insulin Glargine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Insulin Glargine Segment by Application
1.3.1 Global Insulin Glargine Sales Comparison by Application: (2021-2027)
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Global Insulin Glargine Market Size Estimates and Forecasts
1.4.1 Global Insulin Glargine Revenue 2016-2027
1.4.2 Global Insulin Glargine Sales 2016-2027
1.4.3 Insulin Glargine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Insulin Glargine Market Competition by Manufacturers
2.1 Global Insulin Glargine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Insulin Glargine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Insulin Glargine Manufacturing Sites, Area Served, Product Type
2.5 Insulin Glargine Market Competitive Situation and Trends
2.5.1 Insulin Glargine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Insulin Glargine Players Market Share by Revenue
2.5.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Glargine Retrospective Market Scenario by Region
3.1 Global Insulin Glargine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Insulin Glargine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Insulin Glargine Market Facts & Figures by Country
3.3.1 North America Insulin Glargine Sales by Country
3.3.2 North America Insulin Glargine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Insulin Glargine Market Facts & Figures by Country
3.4.1 Europe Insulin Glargine Sales by Country
3.4.2 Europe Insulin Glargine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Insulin Glargine Market Facts & Figures by Region
3.5.1 Asia Pacific Insulin Glargine Sales by Region
3.5.2 Asia Pacific Insulin Glargine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Insulin Glargine Market Facts & Figures by Country
3.6.1 Latin America Insulin Glargine Sales by Country
3.6.2 Latin America Insulin Glargine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Insulin Glargine Market Facts & Figures by Country
3.7.1 Middle East and Africa Insulin Glargine Sales by Country
3.7.2 Middle East and Africa Insulin Glargine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Insulin Glargine Historic Market Analysis by Type
4.1 Global Insulin Glargine Sales Market Share by Type (2016-2021)
4.2 Global Insulin Glargine Revenue Market Share by Type (2016-2021)
4.3 Global Insulin Glargine Price by Type (2016-2021)
5 Global Insulin Glargine Historic Market Analysis by Application
5.1 Global Insulin Glargine Sales Market Share by Application (2016-2021)
5.2 Global Insulin Glargine Revenue Market Share by Application (2016-2021)
5.3 Global Insulin Glargine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Insulin Glargine Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Ganlee
6.2.1 Ganlee Corporation Information
6.2.2 Ganlee Description and Business Overview
6.2.3 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Ganlee Insulin Glargine Product Portfolio
6.2.5 Ganlee Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biocon Insulin Glargine Product Portfolio
6.3.5 Biocon Recent Developments/Updates
7 Insulin Glargine Manufacturing Cost Analysis
7.1 Insulin Glargine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Insulin Glargine
7.4 Insulin Glargine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Insulin Glargine Distributors List
8.3 Insulin Glargine Customers
9 Insulin Glargine Market Dynamics
9.1 Insulin Glargine Industry Trends
9.2 Insulin Glargine Growth Drivers
9.3 Insulin Glargine Market Challenges
9.4 Insulin Glargine Market Restraints
10 Global Market Forecast
10.1 Insulin Glargine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Insulin Glargine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Insulin Glargine by Type (2022-2027)
10.2 Insulin Glargine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Insulin Glargine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Insulin Glargine by Application (2022-2027)
10.3 Insulin Glargine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Insulin Glargine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Insulin Glargine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Insulin Glargine Sales (M mL) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Insulin Glargine Sales (M mL) Comparison by Application (2021-2027)
Table 3. Global Insulin Glargine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Insulin Glargine Covered in This Study
Table 5. Global Insulin Glargine Sales (M mL) of Key Manufacturers (2016-2021)
Table 6. Global Insulin Glargine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Insulin Glargine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Insulin Glargine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Insulin Glargine Average Price (USD/mL) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Insulin Glargine Manufacturing Sites and Area Served
Table 11. Manufacturers Insulin Glargine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Insulin Glargine Sales by Region (2016-2021) & (M mL)
Table 16. Global Insulin Glargine Sales Market Share by Region (2016-2021)
Table 17. Global Insulin Glargine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 19. North America Insulin Glargine Sales Market Share by Country (2016-2021)
Table 20. North America Insulin Glargine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 22. Europe Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 23. Europe Insulin Glargine Sales Market Share by Country (2016-2021)
Table 24. Europe Insulin Glargine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Insulin Glargine Sales by Region (2016-2021) & (M mL)
Table 27. Asia Pacific Insulin Glargine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Insulin Glargine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Insulin Glargine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 31. Latin America Insulin Glargine Sales Market Share by Country (2016-2021)
Table 32. Latin America Insulin Glargine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 35. Middle East and Africa Insulin Glargine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Insulin Glargine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 38. Global Insulin Glargine Sales (M mL) by Type (2016-2021)
Table 39. Global Insulin Glargine Sales Market Share by Type (2016-2021)
Table 40. Global Insulin Glargine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Insulin Glargine Revenue Share by Type (2016-2021)
Table 42. Global Insulin Glargine Price (USD/mL) by Type (2016-2021)
Table 43. Global Insulin Glargine Sales (M mL) by Application (2016-2021)
Table 44. Global Insulin Glargine Sales Market Share by Application (2016-2021)
Table 45. Global Insulin Glargine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Insulin Glargine Revenue Share by Application (2016-2021)
Table 47. Global Insulin Glargine Price (USD/mL) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Insulin Glargine Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. Ganlee Corporation Information
Table 54. Ganlee Description and Business Overview
Table 55. Ganlee Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2016-2021)
Table 56. Ganlee Insulin Glargine Product
Table 57. Ganlee Recent Developments/Updates
Table 58. Biocon Corporation Information
Table 59. Biocon Description and Business Overview
Table 60. Biocon Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2016-2021)
Table 61. Biocon Insulin Glargine Product
Table 62. Biocon Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Insulin Glargine Distributors List
Table 66. Insulin Glargine Customers List
Table 67. Insulin Glargine Market Trends
Table 68. Insulin Glargine Growth Drivers
Table 69. Insulin Glargine Market Challenges
Table 70. Insulin Glargine Market Restraints
Table 71. Global Insulin Glargine Sales Forecast by Type (2022-2027) & (M mL)
Table 72. Global Insulin Glargine Sales Market Share Forecast by Type (2022-2027)
Table 73. Global Insulin Glargine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global Insulin Glargine Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global Insulin Glargine Sales Forecast by Application (2022-2027) & (M mL)
Table 76. Global Insulin Glargine Sales Market Share Forecast by Application (2022-2027)
Table 77. Global Insulin Glargine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global Insulin Glargine Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global Insulin Glargine Sales Forecast by Region (2022-2027) & (M mL)
Table 80. Global Insulin Glargine Sales Market Share Forecast by Region (2022-2027)
Table 81. Global Insulin Glargine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global Insulin Glargine Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Glargine
Figure 2. Global Insulin Glargine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global Insulin Glargine Market Share by Application in 2020 & 2027
Figure 6. Treat Type2 Diabetes
Figure 7. Treat Type1 Diabetes
Figure 8. Global Insulin Glargine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Insulin Glargine Market Size 2016-2027 (US$ Million)
Figure 10. Global Insulin Glargine Sales 2016-2027 (M mL)
Figure 11. Global Insulin Glargine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Insulin Glargine Sales Share by Manufacturers in 2020
Figure 13. Global Insulin Glargine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Insulin Glargine Players: Market Share by Revenue in 2020
Figure 15. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Insulin Glargine Sales Market Share by Region (2016-2021)
Figure 17. Global Insulin Glargine Sales Market Share by Region in 2020
Figure 18. Global Insulin Glargine Revenue Market Share by Region (2016-2021)
Figure 19. Global Insulin Glargine Revenue Market Share by Region in 2020
Figure 20. U.S. Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Taiwan Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Mexico Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Brazil Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Argentina Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Turkey Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Saudi Arabia Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. UAE Insulin Glargine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Sales Market Share of Insulin Glargine by Type (2016-2021)
Figure 43. Sales Market Share of Insulin Glargine by Application (2016-2021)
Figure 44. Sales Market Share of Insulin Glargine by Application in 2020
Figure 45. Revenue Share of Insulin Glargine by Application (2016-2021)
Figure 46. Revenue Share of Insulin Glargine by Application in 2020
Figure 47. Manufacturing Cost Structure of Insulin Glargine
Figure 48. Manufacturing Process Analysis of Insulin Glargine
Figure 49. Insulin Glargine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
